Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q2 2019 13F Holders as of 30 Jun 2019
- Security type / class
- Equity / Common Stock, par value $0.001
- Total 13F shares
- 3,466,005
- Total 13F value
- $9,286,115
- Share change
- +862,381
- Put/Call ratio
- 57%
- SEC-reported price per share
- $2.68
- Number of holders
- 39
- Value change
- +$2,108,302
- Number of buys
- 19
- Number of sells
- 18
- Shares outstanding
- 80,000,000
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
39
Top holders
10
CLDX full security history
Ownership snapshot
Full 13F holder table
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F
Lead comparable stake: 0.68%
Showing 1-6 of 15 holder rows.
Quick read
RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 0.68%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Comparable ownership
Top 5
RENAISSANCE TECHNOLOGIES LLC
0.68%
VANGUARD GROUP INC
0.61%
BlackRock Finance, Inc.
0.38%
DIMENSIONAL FUND ADVISORS LP
0.33%
ACADIAN ASSET MANAGEMENT LLC
0.18%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.68%
|
$2,682,000
545,106 shares
|
— | 31 Mar 2019 |
| VANGUARD GROUP INC |
13F
Company
|
0.61%
|
$2,402,000
488,236 shares
|
— | 31 Mar 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
0.38%
|
$1,491,000
303,095 shares
|
— | 31 Mar 2019 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
0.33%
|
$1,298,000
263,839 shares
|
— | 31 Mar 2019 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
0.18%
|
$723,000
147,038 shares
|
— | 31 Mar 2019 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.15%
|
$609,000
123,700 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
3,466,005
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
39
Q2 2019 holders
39
Holder diff
0
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|